| Holly Anne Halliday, DDS | |
|
247 Pearl St, Burlington, VT 05401-8502 | |
| (802) 863-5447 | |
| Not Available |
| Full Name | Holly Anne Halliday |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 247 Pearl St, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972660330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 2901018396 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Holly Anne Halliday, DDS 251 Fairview East, Essex, ONTARIO N8M 2-R4 Ph: (519) 776-7551 | Holly Anne Halliday, DDS 247 Pearl St, Burlington, VT 05401-8502 Ph: (802) 863-5447 |
News Archive
GlobalPost reports how, spurred by an outbreak of the pneumonic plague in 1994, the Indian city of Surat "successfully went from one of the country's dirtiest cities to one of its cleanest in 18 short months." The news service writes that "after 54 residents died and some 300,000 fled to escape a possible quarantine, the people who stuck around were willing to get with the program - working to eliminate the tons of garbage and overflowing sewers that had inundated the city with disease-carrying rats."
Bemben's lab at the university is currently only one of four labs outside of Japan that has been working with the KAATSU-Master training system, testing the effectiveness of reducing blood flow to exercising muscle.
Cohera Medical, Inc.®, a leading innovator and developer of surgical adhesives and sealants, announced today that the U.S. Food and Drug Administration (FDA) has approved its TissuGlu® Surgical Adhesive.
Resverlogix Corp. has announced that it has received approval by the US Food and Drug Administration (FDA) to initiate a Phase 1a clinical trial of oral RVX-208 in the USA. RVX-208 is a novel first-in-class small molecule that increases the production of ApoA-I and HDL.
Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.
› Verified 1 days ago
Dr. Dara Chira, Dmd, DARA CHIRA, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1073 North Ave, Burlington, VT 05401 Phone: 802-652-1010 Fax: 802-652-0062 | |
Dr. Patrick J Paldino, DDS Dentist Medicare: Medicare Enrolled Practice Location: 789 Pine St, Burlington, VT 05401 Phone: 802-862-1939 Fax: 802-862-2608 | |
Dr. David R Blanck, DDS Dentist Medicare: Medicare Enrolled Practice Location: 66 Colchester Ave, Burlington, VT 05401 Phone: 802-862-8348 | |
Dr. Randall Armand Miller, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 66 Colchester Avenue, Burlington, VT 05401 Phone: 802-862-8348 Fax: 802-862-6823 | |
Dr. David Charles Averill, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 239 Pearl St, Burlington, VT 05401 Phone: 802-864-5315 Fax: 802-864-4434 | |
Dr. Paul A Averill, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 239 Pearl St, Burlington, VT 05401 Phone: 802-864-5315 | |
Dr. Victor L Ratkus, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 227 Colchester Ave, Burlington, VT 05401 Phone: 802-864-0461 Fax: 802-864-0201 |